Page last updated: 2024-10-30

lomerizine and Cranial Nerve II Diseases

lomerizine has been researched along with Cranial Nerve II Diseases in 1 studies

lomerizine: used to treat migraines

Research Excerpts

ExcerptRelevanceReference
"Pre-treatment with tacrolimus markedly protected RGC-5 cells from NMDA-induced neurotoxicity, and then both spontaneous RGC death and degenerative changes to the optic nerve in p50-deficient mice were significantly reduced by the chronic administration of tacrolimus."1.37Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation. ( Hayashi, T; Murata, T; Nakamura-Yanagidaira, T; Sano, K; Takahashi, Y, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura-Yanagidaira, T1
Takahashi, Y1
Sano, K1
Murata, T1
Hayashi, T1

Other Studies

1 other study available for lomerizine and Cranial Nerve II Diseases

ArticleYear
Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation.
    Molecular vision, 2011, Volume: 17

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Calcineurin; Genes, Reporter; Hum

2011